Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials
- PMID: 32478845
- PMCID: PMC7265094
- DOI: 10.1001/jamanetworkopen.2020.10651
Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials
Abstract
This cohort study investigates how the coronavirus disease 2019 (COVID-19) pandemic is associated with national enrollment in cancer clinical trials.
Conflict of interest statement
Figures
Comment in
-
Multicenter Clinical Cancer Research After COVID-19: A Perspective From NRG Oncology.Int J Radiat Oncol Biol Phys. 2020 Oct 1;108(2):483-485. doi: 10.1016/j.ijrobp.2020.06.056. Int J Radiat Oncol Biol Phys. 2020. PMID: 32890539 Free PMC article. No abstract available.
References
-
- GitHub Data from The New York Times based on reports from state and local health agencies. Accessed April 12, 2020. https://github.com/nytimes/covid-19-data
-
- National Clinical Trial Network Group Chairs NCTN Group Chairs: cancer trials take backseat to clinical care amid COVID-19 pandemic. The Cancer Letter Published April 10, 2020. Accessed May 7, 2020. https://cancerletter.com/articles/20200410_1/
-
- National Cancer Institute. Presentations from the 1st virtual joint meeting of NCI Board of Scientific Advisors and National Cancer Advisory Board. April 9, 2020. Accessed April 29, 2020. https://deainfo.nci.nih.gov/advisory/joint/0420/index.htm
-
- US Food and Drug Administration FDA guidance on conduct of clinical trials of medical products during COVID-19 pandemic. Published March 2020. Accessed April 9, 2020. https://www.fda.gov/regulatory-information/search-fda-guidance-documents...
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
